Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 8/20 | 0.40 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.38 |
| ▸ | SELE | P16581 | 4/20 | 0.35 |
| ▸ | SELL | P14151 | 1/20 | 0.34 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18160012 | 1.00 | MAG (0.40) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL18159155 | 0.91 | SIGLEC7 (0.37) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL18165655 | 0.87 | SIGLEC7 (0.39) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL18160016 | 0.87 | SIGLEC7 (0.39) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL18165661 | 0.86 | SIGLEC7 (0.43) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL17945553 | 0.84 | MAG (0.51) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL13059905 | 0.83 | SIGLEC7 (0.41) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL18160014 | 0.83 | SIGLEC7 (0.52) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL13059894 | 0.81 | MAG (0.38) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL18165662 | 0.79 | SELL (0.52) | MAGSIGLEC7SELESELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11732256-B2 | Multivalent glycopeptides that tightly bind to target proteins | BRANDEIS UNIVERSITY (US) | 2023-08-22 | — | — | US | disclosed |
| US-20160304874-A1 | HIGH TEMPERATURE SELECTION OF NUCLEOTIDE-SUPPORTED CARBOHYDRATE VACCINES AND RESULTING GLYCOSYLATED OLIGONUCLEOTIDES | BRANDEIS UNIVERSITY | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304874-A1 | HIGH TEMPERATURE SELECTION OF NUCLEOTIDE-SUPPORTED CARBOHYDRATE VACCINES AND RESULTING GLYCOSYLATED OLIGONUCLEOTIDES | RNGTT, BPGM, TLR9 | MAG 1072/4885SIGLEC7 7/4885SELE 6/4885 |
| US-11732256-B2 | Multivalent glycopeptides that tightly bind to target proteins | SIGLEC7, SIGLEC9, STT3A | MAG 288/4885SIGLEC7 1/4885SELE 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.